Ourofino (BSP:OFSA3) Cyclically Adjusted Revenue per Share: R$18.94 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:OFSA3 Ourofino SA BSP:OFSA3
68 GF Score
Price R$26.80
GF Value R$26.86
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Ourofino Cyclically Adjusted Revenue per Share?

Ourofino BSP:OFSA3 -2.19% 68 Cyclically Adjusted Revenue per Share is R$18.94 as of Mar. 2026. GuruFocus rates BSP:OFSA3 with a GF Score™ of 68/100 and a GF Value™ of R$26.86 (Fairly Valued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Ourofino's adjusted revenue per share for the three months ended in Mar. 2026 was R$4.658. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is R$18.94 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Ourofino's average Cyclically Adjusted Revenue Growth Rate was 8.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-14), Ourofino's current stock price is R$26.80. Ourofino's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was R$18.94. Ourofino's Cyclically Adjusted PS Ratio of today is 1.41.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Ourofino was 1.77. The lowest was 0.94. And the median was 1.30.


Ourofino  (BSP:OFSA3) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Ourofino's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=26.80/18.94
=1.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Ourofino was 1.77. The lowest was 0.94. And the median was 1.30.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Ourofino Cyclically Adjusted Revenue per Share Related Terms


Ourofino Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Ourofino's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ourofino Cyclically Adjusted Revenue per Share Chart

Ourofino Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 17.07 18.42

Ourofino Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.49 17.72 18.03 18.42 18.94

BSP:OFSA3 vs ZTS, UTHR, VTRS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ourofino's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ourofino Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ourofino's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ourofino's Cyclically Adjusted PS Ratio falls into.


BSP:OFSA3
68GF Score
Ourofino SA BSP:OFSA3
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ourofino Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ourofino's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=4.658/175.0655*175.0655
=4.658

Current CPI (Mar. 2026) = 175.0655.

Ourofino Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 2.487 108.851 4.000
201609 2.321 109.986 3.694
201612 1.826 110.802 2.885
201703 1.394 111.869 2.181
201706 2.557 112.115 3.993
201709 2.412 112.777 3.744
201712 3.003 114.068 4.609
201803 1.704 114.868 2.597
201806 2.995 117.038 4.480
201809 2.972 117.881 4.414
201812 3.250 118.340 4.808
201903 1.686 120.124 2.457
201906 3.294 120.977 4.767
201909 2.862 121.292 4.131
201912 3.642 123.436 5.165
202003 2.074 124.092 2.926
202006 3.198 123.557 4.531
202009 4.174 125.095 5.841
202012 4.087 129.012 5.546
202103 3.129 131.660 4.161
202106 4.281 133.871 5.598
202109 4.353 137.913 5.526
202112 5.024 141.992 6.194
202203 3.750 146.537 4.480
202206 4.376 149.784 5.115
202209 5.221 147.800 6.184
202212 6.003 150.207 6.996
202303 3.109 153.352 3.549
202306 4.312 154.519 4.885
202309 4.904 155.464 5.522
202312 5.219 157.148 5.814
202403 3.318 159.372 3.645
202406 4.040 161.052 4.392
202409 5.255 162.342 5.667
202412 6.447 164.740 6.851
202503 3.526 168.102 3.672
202506 4.821 169.670 4.974
202509 6.630 170.739 6.798
202512 7.806 171.765 7.956
202603 4.658 175.066 4.658

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of R$18.94 mean?
Ourofino (BSP:OFSA3) has a Cyclically Adjusted Revenue per Share of R$18.94 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ourofino and its competitors.
Is Ourofino's Cyclically Adjusted Revenue per Share too high?
Ourofino's current Cyclically Adjusted Revenue per Share is R$18.94. Overall, Ourofino has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ourofino's Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
Ourofino's Cyclically Adjusted Revenue per Share of R$18.94 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ourofino and its competitors. Ourofino's current Cyclically Adjusted Revenue per Share is R$18.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ourofino stock overvalued right now?
Based on GuruFocus' analysis, Ourofino (BSP:OFSA3) is currently considered Fairly Valued. The stock's GF Value™ is R$26.86, compared to a current price of R$26.80 — trading 0.2% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is R$18.94. Ourofino's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Ourofino (BSP:OFSA3), the current Cyclically Adjusted Revenue per Share is R$18.94 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ourofino (BSP:OFSA3) Overvalued in 2026?

Based on GuruFocus' analysis, Ourofino stock appears to be undervalued. The current stock price of R$26.80 is trading 0.2% below its estimated GF Value™ of R$26.86. GuruFocus considers Ourofino to be Fairly Valued.

Key valuation signals for BSP:OFSA3:

  • Cyclically Adjusted Revenue per Share: R$18.94
  • GF Value™: R$26.86 vs. price of R$26.80 (0.2% below fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the BSP:OFSA3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ourofino Business Description

Address Anhanguera Highway SP 330, Block C, 2nd floor, Km 298, Industrial District, Cravinhos, SP, BRA, 14140-000
Ourofino SA is engaged in research, development, production and sales of medicines, vaccines and other veterinary products. The company's reportable segments are Production animals, Companion animals, and International operations. It generates maximum revenue from the Production animals segment. The product portfolio includes Anticoccidials, Antimastitics, Biological, Ectoparasiticides, Endectocides, and others.
68GF Score

Get the complete analysis for BSP:OFSA3

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$26.80
Price
R$26.86
GF Value